Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › IL › Glendale Heights › NPI 1225706179
Lab

Best Covid Care LLC

Best Covid Care LLC was paid $671K by Medicaid between Jun 2022 and May 2023, across 4 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 62% of everything it billed.

33Billing provider infoBEST COVID CARE LLC
GLENDALE HEIGHTS, IL 60139
33aNPI1225706179assigned 09/03/2021
28Total paid$671K
24GClaims16,222
24DCodes billed4
24AFirst – last monthJun 2022 – May 2023
Compared with peers

Next to other Clinical Medical Laboratory providers in Illinois

Rank by total paid#81 of 235
Median peer was paid$123K
This provider vs. median5.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20229,754$383K
20236,468$288K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 62% 5,764 2,702 $418K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 21% 6,261 2,762 $141K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 12% 3,458 1,900 $83K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 4.3% 739 543 $29K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCHUCK, MOHAMMED (CO-CEO)